{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T13:48:26Z","timestamp":1784296106113,"version":"3.55.0"},"reference-count":31,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T00:00:00Z","timestamp":1459209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Surgical Infections"],"published-print":{"date-parts":[[2016,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Fournier gangrene (FG) is a fulminant necrotizing infection of the perineal, perianal, and periurethral tissues. The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) scale is used for diagnosis of necrotizing fasciitis. However, data on its relevance and usefulness in FG are lacking. The aim of this study was to evaluate the utility of the LRINEC scale in predicting the outcome of FG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This retrospective case study included 41 patents with FG treated at our institution from 2000 to 2013. The patients were divided into survivors and non-survivors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The mortality rate was 22%. The median age (75 vs. 62.5\u2009y; p\u2009=\u20090.013), rate of co-existing diabetes mellitus (66.7% vs. 3.1%; p\u2009&lt;\u20090.001), and median affected skin surface (4% vs. 1%; p\u2009&lt;\u20090.001) were greater in the non-survivors. Seven of nine patients (77.8%) who did not survive (compared with 37.5% who survived) had a polymicrobial infection (p\u2009=\u20090.032). Of all the causative pathogens isolated,\n                      <jats:italic toggle=\"yes\">Proteus mirabilis<\/jats:italic>\n                      was more common in non-survivors (55.6% vs. 6.3%; p\u2009=\u20090.001). The median calculated LRINEC score for survivors was 5 compared with 10 for the non-survivors (p\u2009&lt;\u20090.001). Regression analysis showed that all the aforementioned variables, except for polymicrobial culture, were significant risk factors for predicting death. The area under the receiver operating characteristic curve for the LRINEC score was the highest, 0.976 (95% confidence interval 0.872\u20130.999; p\u2009&lt;\u20090.0001), and the cut-off value was \u22659 with 93.7% specificity and 100% susceptibility for the prediction of a lethal outcome.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The LRINEC score could be used for prediction of disease severity and outcomes. A threshold of 9 could be a high-value predictor of death during the initial evaluation of patients with FG.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/sur.2015.076","type":"journal-article","created":{"date-parts":[[2016,3,29]],"date-time":"2016-03-29T18:45:03Z","timestamp":1459277103000},"page":"448-453","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":37,"title":["Evaluation of LRINEC Scale Feasibility for Predicting Outcomes of Fournier Gangrene"],"prefix":"10.1177","volume":"17","author":[{"given":"Marius","family":"Kincius","sequence":"first","affiliation":[{"name":"Lithuanian University of Health Sciences","place":["Lithuania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titas","family":"Telksnys","sequence":"additional","affiliation":[{"name":"Lithuanian University of Health Sciences","place":["Lithuania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius","family":"Trumbeckas","sequence":"additional","affiliation":[{"name":"Lithuanian University of Health Sciences","place":["Lithuania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindaugas","family":"Jievaltas","sequence":"additional","affiliation":[{"name":"Lithuanian University of Health Sciences","place":["Lithuania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daimantas","family":"Milonas","sequence":"additional","affiliation":[{"name":"Lithuanian University of Health Sciences","place":["Lithuania"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2016,3,29]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2003.04753.x"},{"key":"e_1_3_2_3_2","first-page":"345","article-title":"Gangrene foudroyante de la verge","volume":"3","author":"Fournier J-A","year":"1883","unstructured":"Fournier J-A. Gangrene foudroyante de la verge. Sem Med, 1883; 3:345\u2013348.","journal-title":"Sem Med"},{"key":"e_1_3_2_4_2","first-page":"131","article-title":"A complex approach to the treatment of Fournier's gangrene","volume":"22","author":"Sroczy\u0144ski M","year":"2013","unstructured":"Sroczy\u0144ski M, , Sebastian M, , Rudnicki J, et al. A complex approach to the treatment of Fournier's gangrene. Adv Clin Exp Med, 2013; 22:131\u2013135.","journal-title":"Adv Clin Exp Med"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.surge.2013.02.001"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000335507"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.asjsur.2012.04.006"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2005.01204.x"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10350-004-6626-x"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.11082.x"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000129486.35458.7D"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2042.2006.01448.x"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(01)67236-7"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1159\/000321691"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2004.03.049"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2009.08.090"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1159\/000070137"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00423-008-0461-9"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000342407"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2168.2000.01497.x"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-005-0777-3"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000339161"},{"key":"e_1_3_2_23_2","first-page":"537","article-title":"Factors affecting mortality in Fournier's gangrene: Experience with fifty-two patients","volume":"53","author":"Ersoz F","year":"2012","unstructured":"Ersoz F, , Sari S, , Arikan S, et al. Factors affecting mortality in Fournier's gangrene: Experience with fifty-two patients. Singapore Med J, 2012; 53:537\u2013540.","journal-title":"Singapore Med J"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/1749-7922-8-13"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-008-9401-4"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000637-200111000-00009"},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","unstructured":"Noton K. Johnson LW Perry T et al. Management of Fournier's gangrene: An eleven year retrospective analysis of early recognition diagnosis and treatment. Presented at the Annual Meeting of the Southeastern Surgical Congress Nashville Tennessee 2002.","DOI":"10.1177\/000313480206800810"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2012.12.041"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2008.05.021"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2012.11291.x"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2006.01.030"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10151-010-0592-1"}],"container-title":["Surgical Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/sur.2015.076","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/sur.2015.076","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/sur.2015.076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:22:55Z","timestamp":1779193375000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/sur.2015.076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,29]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,8,1]]}},"alternative-id":["10.1089\/sur.2015.076"],"URL":"https:\/\/doi.org\/10.1089\/sur.2015.076","relation":{},"ISSN":["1096-2964","1557-8674"],"issn-type":[{"value":"1096-2964","type":"print"},{"value":"1557-8674","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,29]]}}}